Getting a cancer diagnosis can be overwhelming, especially when you live outside the U.S. and wonder whether your treatment plan is the best possible one. This article explores how MD Anderson Cancer Center’s second opinion service—supported by Medebound HEALTHhelps international patients gain access to world-leading oncology expertise without leaving home

This case highlights a 55-year-old woman with advanced pancreatic cancer who sought a remote second opinion through Medebound HEALTH before traveling to the U.S. A video consultation with a leading MD Anderson professor clarified global treatment options, including KRAS-targeted therapies and clinical trial enrollment. The expert’s commitment to serve as her primary physician provided reassurance and direct access to cutting-edge care.

This article highlights key 2025 advances in pancreatic cancer treatment, including new FDA-approved drugs, targeted therapies, and AI-driven care. It features the real story of Mei Ling, a Stage III patient who accessed a U.S. clinical trial through Medebound HEALTH and achieved curative surgery.